|Articles|July 15, 2002
Microelectronic device continues to show promise
Fort Lauderdale, FL-A subretinal micro-photodiode-based silicon chip (Artificial Silicon Retina, ASR) implanted in patients with retinitis pigmentosa (RP) appears to be safe while showing continued improvement in both subjective and objective measures of visual function, said Alan Y. Chow, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology here.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
2
Q&A: Optimizing the ocular surface for light adjustable lens technology
3
Angiogenesis 2026: Continuous AI severity scoring could transform AMD monitoring
4
PRIMA System: A major step in the battle against GA
5
























